Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-22-020005)

Filing Details

Accession Number:: 0001127602-22-020005
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-08-01 16:13:38
Reporting Period:: 2022-08-01

Accepted Time:: 2022-08-01 16:13:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1062822	Lexicon Pharmaceuticals Inc.	LXRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1053890	Raymond Debbane	2445 Technology Forest Blvd. 11Th Floor The Woodlands TX 77381		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-01	982,600	$2.50	5,303,814	No	4	P	Indirect	By Invus US Partners LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Invus US Partners LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	331,545	Direct